SYRA

Syra Health Corp. Class A Common Stock

Delisted

SYRA was delisted on the 17th of April, 2025.

 

About: Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Employees: 162

Financial journalist opinion

Neutral
Seeking Alpha
1 week ago
Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript
Syra Health Corp. (OTC:SYRA) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Corbin Woodhull - Hayden Investor Relations Dr. Deepika Vuppalanchi - Chief Executive Officer Priya Prasad - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen. And welcome to the Syra Health First Quarter 2025 Earnings Conference Call.
Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript
Neutral
PRNewsWire
1 week ago
Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY
Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind. , May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.
Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY
Neutral
PRNewsWire
2 weeks ago
Syra Health To Discuss First Quarter 2025 Financial Results
Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind.
Syra Health To Discuss First Quarter 2025 Financial Results
Neutral
PRNewsWire
1 month ago
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market.
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
Neutral
PRNewsWire
2 months ago
Syra Health Secures $660,000 Population Health Contract Extension
CARMEL, Ind. , March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization.
Syra Health Secures $660,000 Population Health Contract Extension
Neutral
Seeking Alpha
2 months ago
Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript
Syra Health Corp. (NASDAQ:SYRA ) Q4 2024 Earnings Call March 11, 2025 9:00 AM ET Company Participants Brett Maas - Investor Relations Deepika Vuppalanchi - Chair and Chief Executive Officer Priya Prasad - Chief Financial Officer Brett Maas Good morning, everyone, and thank you for joining us for Syra Health's Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct Investor Relations for Syra Health.
Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript
Neutral
PRNewsWire
2 months ago
Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind. , March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.
Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
Neutral
PRNewsWire
2 months ago
Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind.
Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Neutral
PRNewsWire
2 months ago
Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
CARMEL, Ind. , Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee.
Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
Neutral
PRNewsWire
2 months ago
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
Charts implemented using Lightweight Charts™